BridgeBio Pharma, Inc. - 8-K Filing
BridgeBio Pharma's annual meeting on June 22, 2026, resulted in the election of three Class I directors and approval of a stock plan amendment increasing shares available by 2 million. Dr. Randal W. Scott resigned from the board following his term completion. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 Submission of Matters to a Vote of Security Holders, 9.01 Financial Statements and Exhibits)
Tickers: $BBIO